Bonaventura, Aldo http://orcid.org/0000-0002-4747-5535
Mumoli, Nicola
Mazzone, Antonino
Colombo, Alessandra
Evangelista, Isabella
Cerutti, Scilla
Brivio, Lorenza
Vecchié, Alessandra
Bonomi, Alice
Para, Ombretta
Bellizzi, Annamaria
Cei, Marco
Fenu, Patrizia
Tangianu, Flavio
Dentali, Francesco
Cei, Francesco
Article History
Received: 3 September 2021
Accepted: 24 March 2022
First Online: 23 April 2022
Declarations
:
: Aldo Bonaventura and Alessandra Vecchié received a travel grant from Kiniksa Pharmaceuticals Ltd. to attend the 2019 AHA Scientific Sessions and honoraria from Effetti s.r.l. (Milan, Italy) to collaborate on the medical website ExternalRef removed not related to the present work. The other authors have nothing to disclose.
: The research has been conducted in accordance with the Declaration of Helsinki (revised version 2000) following approval of the local Institutional Review Board (Valutazione dell’efficacia di parametri clinici, laboratoristici e radiologici nella predizione dell’efficacia delle terapie in uso per il trattamento della sindrome da distress respiratorio acuta secondaria ad infezione da SARS-CoV-2 [REgistro COvid-19 asST settE LAghi, RECOSTELA; number 150/2021).
: Written informed consent was obtained from all study participants or their legal representatives.
Free to read: This content has been made available to all.